Subscribe To
U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma
Priority Review Continues with Successful Facility Inspections Completed,no Major Review Issues FDA Extends PDUFA Date to February 24, 2024 on Resource Constraints and Agrees to Work with Iovance to Expedite Remaining Review SAN CARLOS, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering […] The post U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action...
Read More
Content Topics
Food
Drug
Administration
Updates
Prescription
User
pdufa
Action
Lifileucel
Treatment
Advanced
Melanoma
Forex
Posted: Sep 14 2023, 22:10
Author Name: forextv
Views: 092112